Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Micke

Showing results (131-140 of 165) with videos related to

Pageof 17
Sort By:
Cancer Letters|February 2, 2013
The prognostic relevance of tumour-infiltrating plasma cells and immunoglobulin kappa C indicates an important role of the humoral immune response in non-small cell lung cancerMiriam Lohr, Karolina Edlund, Johan Botling, et al.
International Journal of Cancer|April 25, 2019
NK- and T-cell subsets in malignant mesothelioma patients: Baseline pattern and changes in the context of anti-CTLA-4 therapyRosa Sottile, Milad Tannazi, Maria H Johansson, et al.
Lung Cancer (Amsterdam, Netherlands)|December 14, 2020
Evaluation of NTRK immunohistochemistry as a screening method for NTRK gene fusion detection in non-small cell lung cancerHedvig Elfving, Erika Broström, Lotte N J Moens, et al.
International Journal of Cancer|April 19, 2018
Expression of scavenger receptor MARCO defines a targetable tumor-associated macrophage subset in non-small cell lung cancerLinnéa La Fleur, Vanessa F Boura, Andrey Alexeyenko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2012
Biomarker discovery in non-small cell lung cancer: integrating gene expression profiling, meta-analysis, and tissue microarray validationJohan Botling, Karolina Edlund, Miriam Lohr, et al.
Plos One|December 14, 2020
PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3Abir Salwa Ali, Seppo W Langer, Birgitte Federspiel, et al.
BMC Cancer|August 7, 2016
Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancerJohanna S M Mattsson, Hans Brunnström, Verena Jabs, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 1, 2025
In Situ Detection of Programmed Cell Death Protein 1 and Programmed Death Ligand 1 Interactions as a Functional Predictor for Response to Immune Checkpoint Inhibition in NSCLCAmanda Lindberg, Lars Muhl, Hui Yu, et al.
Gut|January 20, 2025
Unlocking novel T cell-based immunotherapy for hepatocellular carcinoma through neoantigen-driven T cell receptor isolationPanagiota Maravelia, Haidong Yao, Curtis Cai, et al.
Molecular Cancer Research : MCR|July 13, 2017
Integrative CAGE and DNA Methylation Profiling Identify Epigenetically Regulated Genes in NSCLCMasafumi Horie, Bogumil Kaczkowski, Mitsuhiro Ohshima, et al.
Pageof 17

Showing results (131-140 of 165) with videos related to

Sort By:
Pageof 17
Cancer Letters|February 2, 2013
The prognostic relevance of tumour-infiltrating plasma cells and immunoglobulin kappa C indicates an important role of the humoral immune response in non-small cell lung cancerMiriam Lohr, Karolina Edlund, Johan Botling, et al.
International Journal of Cancer|April 25, 2019
NK- and T-cell subsets in malignant mesothelioma patients: Baseline pattern and changes in the context of anti-CTLA-4 therapyRosa Sottile, Milad Tannazi, Maria H Johansson, et al.
Lung Cancer (Amsterdam, Netherlands)|December 14, 2020
Evaluation of NTRK immunohistochemistry as a screening method for NTRK gene fusion detection in non-small cell lung cancerHedvig Elfving, Erika Broström, Lotte N J Moens, et al.
International Journal of Cancer|April 19, 2018
Expression of scavenger receptor MARCO defines a targetable tumor-associated macrophage subset in non-small cell lung cancerLinnéa La Fleur, Vanessa F Boura, Andrey Alexeyenko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2012
Biomarker discovery in non-small cell lung cancer: integrating gene expression profiling, meta-analysis, and tissue microarray validationJohan Botling, Karolina Edlund, Miriam Lohr, et al.
Plos One|December 14, 2020
PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3Abir Salwa Ali, Seppo W Langer, Birgitte Federspiel, et al.
BMC Cancer|August 7, 2016
Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancerJohanna S M Mattsson, Hans Brunnström, Verena Jabs, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 1, 2025
In Situ Detection of Programmed Cell Death Protein 1 and Programmed Death Ligand 1 Interactions as a Functional Predictor for Response to Immune Checkpoint Inhibition in NSCLCAmanda Lindberg, Lars Muhl, Hui Yu, et al.
Gut|January 20, 2025
Unlocking novel T cell-based immunotherapy for hepatocellular carcinoma through neoantigen-driven T cell receptor isolationPanagiota Maravelia, Haidong Yao, Curtis Cai, et al.
Molecular Cancer Research : MCR|July 13, 2017
Integrative CAGE and DNA Methylation Profiling Identify Epigenetically Regulated Genes in NSCLCMasafumi Horie, Bogumil Kaczkowski, Mitsuhiro Ohshima, et al.
Pageof 17